[HTML][HTML] The key role of NLRP3 and STING in APOL1-associated podocytopathy
J Wu, A Raman, NJ Coffey, X Sheng… - The Journal of …, 2021 - Am Soc Clin Investig
Coding variants in apolipoprotein L1 (APOL1), termed G1 and G2, can explain most excess
kidney disease risk in African Americans; however, the molecular pathways of APOL1 …
kidney disease risk in African Americans; however, the molecular pathways of APOL1 …
[HTML][HTML] The key role of NLRP3 and STING in APOL1-associated podocytopathy
J Wu, A Raman, NJ Coffey, X Sheng… - The Journal of …, 2021 - ncbi.nlm.nih.gov
Coding variants in apolipoprotein L1 (APOL1), termed G1 and G2, can explain most excess
kidney disease risk in African Americans; however, the molecular pathways of APOL1 …
kidney disease risk in African Americans; however, the molecular pathways of APOL1 …
The key role of NLRP3 and STING in APOL1-associated podocytopathy.
J Wu, A Raman, NJ Coffey, X Sheng… - The Journal of …, 2021 - europepmc.org
Coding variants in apolipoprotein L1 (APOL1), termed G1 and G2, can explain most excess
kidney disease risk in African Americans; however, the molecular pathways of APOL1 …
kidney disease risk in African Americans; however, the molecular pathways of APOL1 …
The key role of NLRP3 and STING in APOL1-associated podocytopathy
J Wu, A Raman, NJ Coffey, X Sheng… - The Journal of …, 2021 - pubmed.ncbi.nlm.nih.gov
Coding variants in apolipoprotein L1 (APOL1), termed G1 and G2, can explain most excess
kidney disease risk in African Americans; however, the molecular pathways of APOL1 …
kidney disease risk in African Americans; however, the molecular pathways of APOL1 …
[PDF][PDF] The key role of NLRP3 and STING in APOL1-associated podocytopathy
J Wu, A Raman, NJ Coffey, X Sheng, J Wahba… - 2021 - researchgate.net
African Americans represent 13% of the US population, and yet 35% of patients on chronic
dialysis are African American (1, 2). This excess chronic kidney disease (CKD) risk can …
dialysis are African American (1, 2). This excess chronic kidney disease (CKD) risk can …
The key role of NLRP3 and STING in APOL1-associated podocytopathy.
J Wu, A Raman, NJ Coffey, X Sheng… - Journal of Clinical …, 2021 - go.gale.com
Coding variants in apolipoprotein L1 (APOL1), termed G1 and G2, can explain most excess
kidney disease risk in African Americans; however, the molecular pathways of APOL1 …
kidney disease risk in African Americans; however, the molecular pathways of APOL1 …
The key role of NLRP3 and STING in APOL1-associated podocytopathy
J Wu, A Raman, NJ Coffey, X Sheng… - Journal of Clinical …, 2021 - search.proquest.com
Coding variants in apolipoprotein L1 (APOL1), termed G1 and G2, can explain most excess
kidney disease risk in African Americans; however, the molecular pathways of APOL1 …
kidney disease risk in African Americans; however, the molecular pathways of APOL1 …
[引用][C] The key role of NLRP3 and STING in APOL1-associated podocytopathy
J Wu, A Raman, NJ Coffey, X Sheng, J Wahba… - Journal of Clinical …, 2021 - cir.nii.ac.jp
The key role of NLRP3 and STING in APOL1-associated podocytopathy | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …